Schmid John P.
Xeris Biopharma Holdings, Inc. · Director
Schmid John P. is listed in filings as Director at Xeris Biopharma Holdings, Inc.. This profile follows SEC Form 4 activity through Apr 22, 2026, including purchase activity and sale activity. Recent filings connect the profile to Xeris Biopharma Holdings, Inc. (XERS), Poseida Therapeutics, Inc. (PSTX), Design Therapeutics, Inc. (DSGN), and BridgeBio Oncology Therapeutics Inc. (BBOT). The current snapshot covers public activity from Jun 17, 2024 to Apr 22, 2026. Reported amounts are shown as $10.1K to $530.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $30k522 shares | SellMar 30, 2026 | $57.40 | $58.00 | |
| $427k7.5k shares | SellMar 30, 2026 | $56.70 | $58.00 | |
| $702k12.6k shares | SellMar 30, 2026 | $55.71 | $58.00 |